EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudiePragmatische StudieOpen Access

Transfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT

Abha Maheshwari iD, Vasha Bari iD, Jennifer L Bell iD, Siladitya Bhattacharya iD, Priya Bhide iD, Ursula Bowler iD, Daniel Brison iD, Tim Child iD, Huey Yi Chong iD, Ying Cheong iD, Christina Cole iD, Arri Coomarasamy iD und 21 weitere

Health Technology Assessment · 2022-05 · 26 (25) · 1-142

DOI: 10.3310/aefu1104 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Health Technology Assessment, 2022-05. Verfasst von Abha Maheshwari und 32 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Fertility Centre, NHS Grampian and University of Aberdeen, Aberdeen, UK. Hauptthemen laut MEDLINE: Embryo Transfer, Ovarian Hyperstimulation Syndrome. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chief Scientist Office, Health Technology Assessment programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Freezing all embryos, followed by thawing and transferring them into the uterine cavity at a later stage (freeze-all), instead of fresh-embryo transfer may lead to improved pregnancy rates and fewer complications during in vitro fertilisation and pregnancies resulting from it.

Objective

We aimed to evaluate if a policy of freeze-all results in a higher healthy baby rate than the current policy of transferring fresh embryos.

Design

This was a pragmatic, multicentre, two-arm, parallel-group, non-blinded, randomised controlled trial.

Setting

Eighteen in vitro fertilisation clinics across the UK participated from February 2016 to April 2019.

Participants

Couples undergoing their first, second or third cycle of in vitro fertilisation treatment in which the female partner was aged < 42 years.

Interventions

If at least three good-quality embryos were present on day 3 of embryo development, couples were randomly allocated to either freeze-all (intervention) or fresh-embryo transfer (control). Outcomes The primary outcome was a healthy baby, defined as a live, singleton baby born at term, with an appropriate weight for their gestation. Secondary outcomes included ovarian hyperstimulation, live birth and clinical pregnancy rates, complications of pregnancy and childbirth, health economic outcome, and State–Trait Anxiety Inventory scores.

Results

A total of 1578 couples were consented and 619 couples were randomised. Most non-randomisations were because of the non-availability of at least three good-quality embryos ( n = 476). Of the couples randomised, 117 (19%) did not adhere to the allocated intervention. The rate of non-adherence was higher in the freeze-all arm, with the leading reason being patient choice. The intention-to-treat analysis showed a healthy baby rate of 20.3% in the freeze-all arm and 24.4% in the fresh-embryo transfer arm (risk ratio 0.84, 95% confidence interval 0.62 to 1.15). Similar results were obtained using complier-average causal effect analysis (risk ratio 0.77, 95% confidence interval 0.44 to 1.10), per-protocol analysis (risk ratio 0.87, 95% confidence interval 0.59 to 1.26) and as-treated analysis (risk ratio 0.91, 95% confidence interval 0.64 to 1.29). The risk of ovarian hyperstimulation was 3.6% in the freeze-all arm and 8.1% in the fresh-embryo transfer arm (risk ratio 0.44, 99% confidence interval 0.15 to 1.30). There were no statistically significant differences between the freeze-all and the fresh-embryo transfer arms in the live birth rates (28.3% vs. 34.3%; risk ratio 0.83, 99% confidence interval 0.65 to 1.06) and clinical pregnancy rates (33.9% vs. 40.1%; risk ratio 0.85, 99% confidence interval 0.65 to 1.11). There was no statistically significant difference in anxiety scores for male participants (mean difference 0.1, 99% confidence interval –2.4 to 2.6) and female participants (mean difference 0.0, 99% confidence interval –2.2 to 2.2) between the arms. The economic analysis showed that freeze-all had a low probability of being cost-effective in terms of the incremental cost per healthy baby and incremental cost per live birth.

Limitations

We were unable to reach the original planned sample size of 1086 and the rate of non-adherence to the allocated intervention was much higher than expected.

Conclusion

When efficacy, safety and costs are considered, freeze-all is not better than fresh-embryo transfer.

Trial registration

This trial is registered as ISRCTN61225414. Funding This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 26, No. 25. See the NIHR Journals Library website for further project information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferOvarian Hyperstimulation SyndromeFemaleFertilization in VitroFreezingHumansLive BirthMalePregnancyPregnancy Rate

Stichwörter der Autor:innen

COST-BENEFIT ANALYSISEMBRYO TRANSFERFERTILISATION IN VITROFREEZINGFROZEN EMBRYOSHEALTHY BABYLIVE BIRTHOVARIAN HYPERSTIMULATION SYNDROMEPREGNANCYRANDOMISED CONTROLLED TRIAL

Autor:innen und Institutionen

  • Aberdeen Fertility Centre, NHS Grampian and University of Aberdeen, Aberdeen, UK.
  • Clinical Trials Unit National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Assisted Conception Unit, Homerton University Hospital NHS Foundation Trust and Queen Mary University of London, London, UK.
  • Assisted Conception Unit, Manchester University NHS Foundation Trust, Manchester, UK.
  • Oxford Fertility, The Fertility Partnership, University of Oxford, Oxford, UK.
  • Complete Fertility Centre, University of Southampton, Southampton, UK.

ORCID-Profile: Abha Maheshwari, Vasha Bari, Jennifer L Bell, Siladitya Bhattacharya, Priya Bhide, Ursula Bowler, Daniel Brison, Tim Child, Huey Yi Chong, Ying Cheong, Christina Cole, Arri Coomarasamy, Rachel Cutting, Fiona Goodgame, Pollyanna Hardy, Haitham Hamoda, Edmund Juszczak, Yacoub Khalaf, Andrew King, Jennifer J Kurinczuk, Stuart Lavery, Louise Linsell, Nick Macklon, Raj Mathur, David Murray, Jyotsna Pundir, Nick Raine-Fenning, Lynne Robinson, Graham Scotland, Kayleigh Stanbury, Stephen Troup

Förderung

  • Chief Scientist Office
  • Health Technology Assessment programme

Zitieren

APA

Maheshwari, A., Bari, V., Bell, J. L., Bhattacharya, S., Bhide, P., Bowler, U., Brison, D., Child, T., Chong, H. Y., Cheong, Y., Cole, C., Coomarasamy, A., Cutting, R., Goodgame, F., Hardy, P., Hamoda, H., Juszczak, E., Khalaf, Y., King, A., …, & Troup, S. (2022). Transfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT. Health Technology Assessment, 26(25), 1-142. https://doi.org/10.3310/aefu1104

Vancouver

Maheshwari A, Bari V, Bell JL, Bhattacharya S, Bhide P, Bowler U, et al. Transfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT. Health Technology Assessment. 2022;26(25):1-142. doi:10.3310/aefu1104

BibTeX
@article{Maheshwari2022,
  author = {Maheshwari, Abha and Bari, Vasha and Bell, Jennifer L and Bhattacharya, Siladitya and Bhide, Priya and Bowler, Ursula and Brison, Daniel and Child, Tim and Chong, Huey Yi and Cheong, Ying and Cole, Christina and Coomarasamy, Arri and Cutting, Rachel and Goodgame, Fiona and Hardy, Pollyanna and Hamoda, Haitham and Juszczak, Edmund and Khalaf, Yacoub and King, Andrew and Kurinczuk, Jennifer J and Lavery, Stuart and Lewis-Jones, Clare and Linsell, Louise and Macklon, Nick and Mathur, Raj and Murray, David and Pundir, Jyotsna and Raine-Fenning, Nick and Rajkohwa, Madhurima and Robinson, Lynne and Scotland, Graham and Stanbury, Kayleigh and Troup, Stephen},
  title = {Transfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT},
  journal = {Health Technology Assessment},
  year = {2022},
  volume = {26},
  number = {25},
  pages = {1--142},
  doi = {10.3310/aefu1104}
}
Kostenlos starten →